# Colgate-Palmolive (CL) — Analyst Forecast

CL · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/cl/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 13 | 11 | 0 | 24 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $87.00 | $97.38 | $109.00 | 8 |

Last price $92.67 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 5, 2026 | Wells Fargo | Maintained | Equal-Weight | $90.00 |
| Sep 21, 2026 | Piper Sandler | Maintained | Overweight | $95.00 |
| Sep 8, 2026 | RBC Capital | Maintained | Outperform | $104.00 |
| Aug 3, 2026 | Evercore ISI Group | Maintained | Outperform | $101.00 |
| Aug 3, 2026 | RBC Capital | Maintained | Outperform | $104.00 |
| Aug 3, 2026 | JP Morgan | Maintained | Overweight | $103.00 |
| Aug 3, 2026 | TD Cowen | Maintained | Hold | $90.00 |
| Aug 3, 2026 | UBS | Maintained | Buy | $109.00 |
| Jul 21, 2026 | Barclays | Maintained | Equal-Weight | $87.00 |
| Jul 16, 2026 | UBS | Maintained | Buy | $106.00 |
| Jul 16, 2026 | JP Morgan | Maintained | Overweight | $104.00 |
| Jul 14, 2026 | Citigroup | Maintained | Buy | $110.00 |
| Jul 9, 2026 | Piper Sandler | Maintained | Overweight | $96.00 |
| Jul 8, 2026 | Wells Fargo | Maintained | Equal-Weight | $95.00 |
| Jun 11, 2026 | Bernstein | Initiated Coverage | Market Perform | $96.00 |
| May 5, 2026 | Barclays | Maintained | Equal-Weight | $80.00 |
| May 4, 2026 | RBC Capital | Maintained | Outperform | $102.00 |
| May 4, 2026 | UBS | Maintained | Buy | $100.00 |
| May 4, 2026 | JP Morgan | Maintained | Overweight | $96.00 |
| Apr 23, 2026 | Morgan Stanley | Maintained | Overweight | $95.00 |

## Frequently Asked Questions

### What is the price target for CL stock?

The average 12-month analyst price target for Colgate-Palmolive (CL) is $97.38, with a high estimate of $109.00 and a low of $87.00, across 8 analysts.

### Is CL a buy, sell, or hold?

Analysts covering Colgate-Palmolive currently average a Buy rating: 13 buy, 11 hold and 0 sell, from 24 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for CL?

The average price target of $97.38 implies 5.08% upside from the last price of $92.67.

### What is the latest analyst rating on CL?

On Oct 5, 2026, Wells Fargo maintained Colgate-Palmolive at Equal-Weight with a price target of $90.00.

## Similar Stocks

- [CHD](https://www.lighthorse.io/tickers/chd) — Church & Dwight Company, Inc. Common Stock
- [CLX](https://www.lighthorse.io/tickers/clx) — Clorox Company (The) Common Stock
- [IPAR](https://www.lighthorse.io/tickers/ipar) — Interparfums, Inc. - Common Stock
- [PG](https://www.lighthorse.io/tickers/pg) — Procter & Gamble Company (The) Common Stock
- [KO](https://www.lighthorse.io/tickers/ko) — Coca-Cola Company (The) Common Stock
- [KMB](https://www.lighthorse.io/tickers/kmb) — Kimberly-Clark Corporation - Common Stock
- [MDLZ](https://www.lighthorse.io/tickers/mdlz) — Mondelez International, Inc. - Class A Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).